Three Ways to Get Rich in the Market’s Most Volatile Sector
Apr 5th, 2008 | By Dr. George Huang | Category: Stock Market InvestingIn 2002, Alkermes thought it had a winner on its hands… The small biotech and its Big Pharma partner, Johnson & Johnson, had developed the drug Risperdal Consta to combat schizophrenia. It was a great deal for a while… The market assumed the drug would be approved by the FDA the first time around.